- Report
- April 2024
- 180 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- February 2025
- 187 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- January 2025
- 185 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- June 2024
- 200 Pages
Global
From €7621EUR$7,950USD£6,368GBP
- Drug Pipelines
- March 2025
- 450 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- March 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- March 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- March 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- December 2024
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- September 2024
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- August 2024
- 116 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- June 2024
- 182 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- March 2025
- 150 Pages
Global
From €4650EUR$4,850USD£3,885GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- December 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Report
- May 2024
- 200 Pages
Global
From €3978EUR$4,150USD£3,324GBP
- Report
- May 2024
- 200 Pages
Global
From €3978EUR$4,150USD£3,324GBP
- Report
- May 2024
- 200 Pages
Global
From €3978EUR$4,150USD£3,324GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more